Alopecia Areata: Evidence-Based Treatments

Seminars in Cutaneous Medicine and Surgery

Volumn 28, Issue 1, 2009, Pages 15-18

  Garg, Seema ^a   Messenger, Andrew G ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; DESOXIMETASONE; DIPHENCYPRONE; DITHRANOL; EFALIZUMAB; ETANERCEPT; HYDROCORTISONE; HYDROCORTISONE ACETATE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MINOXIDIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISOLONE; PSORALEN; SALAZOSULFAPYRIDINE; TACROLIMUS; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE;

ACNE; ADRENAL FUNCTION; ALOPECIA AREATA; ALOPECIA TOTALIS; BIOLOGICAL THERAPY; CATARACT; CERVICAL LYMPHADENOPATHY; CLINICAL TRIAL; CONTACT URTICARIA; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG ERUPTION; DYSCHROMIA IN CONFETTI; ECZEMA; EVIDENCE BASED MEDICINE; FEVER; FOAM; HAIR TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOTHERAPY; LOTION; LYMPHADENOPATHY; MENTAL STRESS; OBESITY; OCCIPTAL LYMPHADENOPATHY; PATIENT COUNSELING; PHOTODYNAMIC THERAPY; PIGMENT DISORDER; PUVA; QUALITY OF LIFE; RECURRENT DISEASE; RELAPSE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN ALLERGY; SKIN ATROPHY; SKIN EDEMA; VITILIGO;

ADOLESCENT; ADRENAL CORTEX HORMONES; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; PHOTOCHEMOTHERAPY; REMISSION, SPONTANEOUS; YOUNG ADULT;

EID: 63049129000     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2008.12.002     Document Type: Review

References (68)

1. Safavi K.H., Muller S.A., Suman V.J., et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70 (1995) 628-633
2. Price V.H. Alopecia areata: Clinical aspects. J Invest Dermatol 96 (1991) 68S
3. McDonagh A.J.G., and Messenger A.G. The pathogenesis of alopecia areata. Dermatol Clin 14 (1996) 661-670
4. Jackow C., Puffer N., Hordinsky M., et al. Alopecia areata and cytomegalovirus infection in twins: Genes versus environment?. J Am Acad Dermatol 38 (1998) 418-425
5. Martinez-Mir A., Zlotogorski A., Gordon D., et al. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet 80 (2007) 316-328
6. Tobin D.J., Orentreich N., Fenton D.A., et al. Antibodies to hair follicles in alopecia areata. J Invest Dermatol 102 (1994) 721-724
7. Tobin D.J., Hann S.K., Song M.S., et al. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol 133 (1997) 57-61
8. Whiting D.A. Histopathologic features of alopecia areata: A new look. Arch Dermatol 139 (2003) 1555-1559
9. Gilhar A., Ullmann Y., Berkutzki T., et al. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101 (1998) 62-67
10. Mitchell A.J., and Krull E.A. Alopecia areata: Pathogenesis and treatment. J Am Acad Dermatol 11 (1984) 763-775
11. Delamere F.M., Sladden M.M., Dobbins H.M., et al. Interventions for alopecia areata. Cochrane Database Syst Rev (2008) CD004413
12. MacDonald Hull S.P., Wood M.L., Hutchinson P.E., et al. Guidelines for the management of alopecia areata. Br J Dermatol 149 (2003) 692-699
13. Tosti A., Iorizzo M., Botta G.L., et al. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 20 (2006) 1243-1247
14. Tosti A., Piraccini B.M., Pazzaglia M., et al. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 49 (2003) 96-98
15. Mancuso G., Balducci A., Casadio C., et al. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol 42 (2003) 572-575
16. Charuwichitratana S., Wattanakrai P., and Tanrattanakorn S. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream. Arch Dermatol 136 (2000) 1276-1277
17. Kalkoff K.W., and Macher E. Growing of hair in alopecia areata and maligna after intracutaneous hydrocortisone injection [in German]. Hautarzt 9 (1958) 441-451
18. Porter D., and Burton J.L. A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata. Br J Dermatol 85 (1971) 272-273
19. Kubeyinje E.P. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs. East Afr Med J 71 (1994) 674-675
20. Dillaha C.J., and Rothman S. Treatment of alopecia areata totalis and universalis with cortisone acetate. J Invest Dermatol 18 (1952) 5-6
21. Winter R.J., Kern F., and Blizzard R.M. Prednisone therapy for alopecia areata. A follow-up report. Arch Dermatol 112 (1976) 1549-1552
22. Burton J.L., and Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol 55 (1975) 493-496
23. Olsen E.A., Carson S.C., and Turney E.A. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 128 (1992) 1467-1473
24. Friedli A., Labarthe M.P., Engelhardt E., et al. Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 39 (1998) 597-602
25. Sharma V.K. Pulsed administration of corticosteroids in the treatment of alopecia areata. Int J Dermatol 35 (1996) 133-136
26. Kar B.R., Handa S., Dogra S., et al. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 52 (2005) 287-290
27. Happle R., Hausen B.M., and Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol 63 (1983) 49-52
28. Wilkerson M.G., Connor T.H., Henkin J., et al. Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay. J Am Acad Dermatol 17 (1987) 606-611
29. Happle R., Klein H.M., and Macher E. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res 278 (1986) 214-218
30. Herbst V., Zoller M., Kissling S., et al. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. Eur J Dermatol 16 (2006) 537-542
31. Happle R. Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res 267 (1980) 109-114
32. Hoffmann R., Wenzel E., Huth A., et al. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 103 (1994) 530-533
33. Wiseman M.C., Shapiro J., MacDonald N., et al. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 137 (2001) 1063-1068
34. Henderson C.A., and Ilchyshyn A. Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis. Br J Dermatol 133 (1995) 496-497
35. Tosti A., Guerra L., and Bardazzi F. Contact urticaria during topical immunotherapy. Contact Dermatitis 21 (1989) 196-197
36. van der Steen P.H., van Baar H.M., Happle R., et al. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 24 (1991) 227-230
37. Rokhsar C.K., Shupack J.L., Vafai J.J., et al. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 39 (1998) 751-761
38. Gordon P.M., Aldrige R.D., McVittie E., et al. Topical diphencyprone for alopecia areata: Evaluation of 48 cases after 30 months' follow-up. Br J Dermatol 134 (1996) 869-871
39. MacDonald Hull S., Pepall L., and Cunliffe W.J. Alopecia areata in children: Response to treatment with diphencyprone. Br J Dermatol 125 (1991) 164-168
40. Schuttelaar M.L., Hamstra J.J., Plinck E.P., et al. Alopecia areata in children: Treatment with diphencyprone. Br J Dermatol 135 (1996) 581-585
41. Lassus A., Eskelinen A., and Johansson E. Treatment of alopecia areata with three different PUVA modalities. Photodermatol 1 (1984) 141-144
42. Mitchell A.J., and Douglass M.C. Topical photochemotherapy for alopecia areata. J Am Acad Dermatol 12 (1985) 644-649
43. van der Schaar W.W., and Sillevis Smith J.H. An evaluation of PUVA-therapy for alopecia areata. Dermatologica 168 (1984) 250-252
44. Taylor C.R., and Hawk J.L. PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years' experience at St John's Institute of Dermatology. Br J Dermatol 133 (1995) 914-918
45. Healy E., and Rogers S. PUVA treatment for alopecia areata-Does it work?. A retrospective review of 102 cases. Br J Dermatol 129 (1993) 42-44
46. Tosti A., De Padova M.P., Minghetti G., et al. Therapies versus placebo in the treatment of patchy alopecia areata. J Am Acad Dermatol 15 (1986) 209-210
47. Vestey J.P., and Savin J.A. A trial of 1% minoxidil used topically for severe alopecia areata. Acta Derm venereol 66 (1986) 179-180
48. Fransway A.F., and Muller S.A. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata. Cutis 41 (1988) 431-435
49. Price V.H. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol 16 (1987) 730-736
50. Nelson D.A., and Spielvogel R.L. Anthralin therapy for alopecia areata. Int J Dermatol 24 (1985) 606-607
51. Fiedler-Weiss V.C., and Buys C.M. Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol 123 (1987) 1491-1493
52. Schmoeckel C., Weissmann I., Plewig G., et al. Treatment of alopecia areata by anthralin-induced dermatitis. Arch Dermatol 115 (1979) 1254-1255
53. Gupta A.K., Ellis C.N., Cooper K.D., et al. Oral cyclosporin for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 22 (1990) 242-250
54. Shapiro J., Lui H., Tron V., et al. Systemic cyclosporin and low-dose prednisone in the treatment of chronic severe alopecia areata: A clinical and immunopathologic evaluation. J Am Acad Dermatol 36 (1997) 114-117
55. Bakar O., and Gurbuz O. Is there a role for sulfasalazine in the treatment of alopecia areata?. J Am Acad Dermatol 57 (2007) 703-706
56. Ellis C.N., Brown M.F., and Voorhees J.J. Sulfasalazine for alopecia areata. J Am Acad Dermatol 46 (2002) 541-544
57. Joly P. The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis. J Am Acad Dermatol 55 (2006) 632-636
58. Price V.H., Willey A., and Chen B.K. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 52 (2005) 138-139
59. Kose O., Safali M., Bulent Tastan H., et al. Mycophenolate mofetil in extensive alopecia areata: no effect in seven patients. Dermatology 209 (2004) 69-70
60. Bissonnette R., Shapiro J., Zeng H., et al. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol 143 (2000) 1032-1035
61. Fernandez-Guarino M., Harto A., Garcia-Morales I., et al. Failure to treat alopecia areata with photodynamic therapy. Clin Exp Dermatol 33 (2008) 585-587
62. Ettefagh L., Nedorost S., and Mirmirani P. Alopecia areata in a patient using infliximab: New insights into the role of tumor necrosis factor on human hair follicles. Arch Dermatol 140 (2004) 1012
63. Fabre C., and Dereure O. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab. Dermatology 216 (2008) 185-186
64. Tosti A., Pazzaglia M., Starace M., et al. Alopecia areata during treatment with biologic agents. Arch Dermatol 142 (2006) 1653-1654
65. Strober B.E., Siu K., Alexis A.F., et al. Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study. J Am Acad Dermatol 52 (2005) 1082-1084
66. Price V.H., Hordinsky M.K., Olsen E.A., et al. Subcutaneous efalizumab is not effective in the treatment of alopecia areata. J Am Acad Dermatol 58 (2008) 395-402
67. Bui K., Polisetty S., Gilchrist H., et al. Successful treatment of alopecia universalis with alefacept: A case report and review of the literature. Cutis 81 (2008) 431-434
68. Tosti A., Bellavista S., and Iorizzo M. Alopecia areata: A long term follow-up study of 191 patients. J Am Acad Dermatol 55 (2006) 438-441